[Letter: Tinea faciei exacerbated by topical immunomodulation: Two case reports].
Tinea faciei has commonly been included within the spectrum of tinea corporis. We report two pediatrics cases of tinea faciei that have been evaluated in our unit. Both were exacerbated by topical application of pimecrolimus cream. It is important to note the exacerbation of dermatophyte infection by pimecrolimus in addition to the better known exacerbation by topical corticosteroids.
Ruiz-Villaverde
Ricardo
R
Sanchez-Cano
Daniel
D
D000287:Administration, Topical; D002675:Child, Preschool; D003508:Cycloheptanes / Q000627:therapeutic use; D018450:Disease Progression; D005260:Female; D006118:Griseofulvin / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014005:Tinea / Q000188:drug therapy* / Q000473:pathology*
D003508:Cycloheptanes; D007093:Imidazoles; D007166:Immunosuppressive Agents; D006118:Griseofulvin; C117268:pimecrolimus; C118963:eberconazole; D016559:Tacrolimus
Tiña faciei exacerbada por inmunomodulación tópica: A propósito de 2 casos.